Teddy Mamo, MD, PhD

Resident, Department of Laboratory Medicine and Pathology

Teddy Mamo

Contact Info

MD, Mayo Clinic School of Medicine, 2019

PhD, Mayo Clinic School of Medicine, 2019

Summary

Teddy has lived in many places but after spending 8 years in Rochester, MN to complete his MD/PhD training at the Mayo clinic, he considers Minnesota home. Before that, he graduated from the Nanotechnology Engineering program at the University of Waterloo in Canada. He chose the UMN Residency Program because of its strong CP training and the dedication to residents’ learning with an emphasis on an inclusive learning environment. Before joining the CP program, he completed a Pediatrics Internship at UTSW in Dallas, TX and spent a year with Dr. David McKenna at the UMN doing a Cell Therapy Post-Doctoral Fellowship. In his free time, he enjoys the nature scenes of the Twin Cities. His main hobbies are kayaking, paddle boarding and playing/watching soccer.

Research

Publications

  1. Mamo, T, Hippen, KL, MacMillan, ML, Brunstein, CG, Miller, JS, Wagner, JE, Blazar, BR, and McKenna, DH, “Regulatory T Cells: A Review of Manufacturing and Clinical Utility”, Transfusion, Under Review.
  2. Mamo T, Williams SM, Kinney S, Tessier KM, DeFor T, Cooley S, Miller JS and McKenna DH, “Infusion Reactions in Natural Killer Cell Immunotherapy: A Retrospective Review”, Cytotherapy, 2021 May 9; S1465-3249(21)00215-2.
  3. Bures Z, Mamo T, Vlcek M, Lu L, Yaszemski, MJ, “Signal protein-functionalized gold nanoparticles for nuclear targeting into osteosarcoma cells for use in radiosensitization experiments”, Neoplasma, 2020 May; 67(3):576-583.
  4. Gustafson CT, Mamo T, Maran A, Yaszemski MJ, “Efflux inhibition by IWR-1-endo confers sensitivity to doxorubicin effects in osteosarcoma cells”, Biochem Pharmacol. 2018 Apr; 150:141-149.
  5. Mamo T, Mladek AC, Shogren KL, Gustafson C, Gupta SK, Riester SM, Maran A, Galindo M, van Wijnen AJ, Sarkaria JN, Yaszemski MJ, “Inhibiting DNA-PKcs Radiosensitizes Human Osteosarcoma Cells”, Biochem Biophys Res Commun. 2017 Apr 29; 486 (2):307-313.
  6. Gustafson CT, Mamo T, Shogren KL, Maran A, Yaszemski MJ, “FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases”, Front Pharmacol. 2017 May 23; 8:285.
  7. Gustafson CT, Mamo T, Maran A, Yaszemski MJ, "Molecular strategies for modulating Wnt signaling", Front Biosci (Landmark Ed). 2017 Jan 1; 22:137-156.
  8. Liu X, Miller AL 2nd, Waletzki BE, Mamo TK, Yaszemski MJ, Lu L, "Hydrolysable core crosslinked particles for receptor-mediated pH-sensitive anticancer drug delivery" New J Chem. 2015 Nov 1;39(11):8840-8847.
  9. Mamo T, Poland GA., “Nanovaccinology: The next generation of vaccines meets 21st century materials science and engineering” Vaccine. 2012 Oct 19; 30 (47) : 6609-11.
  10. Sadatmousavi P, Mamo T, Chen P, “Diethylene Glycol (DEG) Functionalized Self-Assembling Peptide Nanofibers”, Acta Biomater. 2012 Sep; 8(9) : 3241-50.
  11. Fung SY, Yang H, Sadatmousavi P, Sheng YB, Mamo T, Nazarian R, Chen P, "Amino Acid Pairing for De Novo Design of Self-Assembling Peptides and Their Drug Delivery Potential", Adv Funct Mater, 2011 July; 21 (13) : 2456-2464.
  12. Mamo T, Moseman EA, Kolishetti N, Salvador-Morales C, Shi J, Kuritzkes DR, Langer R, von Andrian U, Farokhzad OC. “Emerging Nanotechnology Approaches for Treatment and Prevention of HIV/AIDS”, Nanomedicine (Lond). 2010 Feb;5(2):269-85.